ArticleUrolithiasis2025
Age-dependent predictive limitations of the MAP score in standard percutaneous nephrolithotomy.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mayo Adhesive Probability (MAP) score, based on preoperative computed tomography, has been proposed as a predictor of complications following percutaneous nephrolithotomy (PCNL). However, the modifying effect of patient age on this association remains unclear. This study aimed to evaluate the age-dependent predictive performance of the MAP score for key postoperative outcomes in patients undergoing standard PCNL for renal stones ≥ 2 cm. A total of 417 patients were retrospectively analyzed and stratified into three age groups: Group 1 (20–39 years), Group 2 (40–59 years), and Group 3 (60–79 years). Associations between MAP score (categorized as < 3 or ≥ 3) and postoperative complications, including significant hemoglobin decline (≥ 2 g/dL) and fever (> 38 °C), were assessed within and across age groups. In the overall cohort, MAP score ≥ 3 was significantly associated with both hemoglobin drop (OR: 4.664, p < 0.001) and postoperative fever (OR: 4.301, p < 0.001). These associations remained significant in patients under 60 years of age, but not in those aged 60 or older (p = 0.574 and p = 0.549, respectively). These findings suggest that while the MAP score may serve as a useful tool for perioperative risk stratification in younger patients, its predictive capacity may be attenuated in older individuals due to the increasing influence of comorbidities and age-related physiological changes. Age-specific considerations should therefore be integrated into preoperative assessment protocols to optimize surgical planning and outcomes.
Indexed as
Identifiers
41143989What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.